Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Latest filing published 08 Sept 2026 for Opus Genetics, Inc., €110k. Read the official filing
Filing timeline
BuySaleRobert E. Gagnon
Insider track record
Disclosed buys
0
Disclosed sells
24
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert E. Gagnon: trading record in brief
Filings by Robert E. Gagnon span 3 companies, the busiest being Verastem, Inc., Opus Genetics, Inc. and Harvard Bioscience Inc. We count 32 filings; the first trade dates from 1 January 2016 and the latest from 3 September 2026.
The open-market record consists of 24 sales worth €452k, with no purchase. Outside the open market, there are 8 share grants. 2026 to date brings no purchases and 3 sales.
The latest filing, published on 8 September 2026, reports an open-market sale of €110k in Opus Genetics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert E. Gagnon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
28,000 shares@ US$4.5433Common StockSEC:0001140361-26-035912:0
7,783 shares@ US$2.94770.0012% mcap26.5% of flowCommon StockSEC:0000905148-26-003351:0
16,556 sharesCommon StockSEC:0001171843-26-004057:0
7,842 shares@ US$5.18460.0022% mcap100.0% of flowCommon StockSEC:0000905148-26-001862:0
400,000 shares0Common StockSEC:0000905148-26-000354:0
283 shares@ US$9.140.6% of flowCommon StockSEC:0001104659-25-122576:0
281 shares@ US$9.990.6% of flowCommon StockSEC:0001104659-25-091361:0
200,000 shares0Common StockSEC:0000905148-25-003320:0
110,000 shares0Common StockSEC:0001104659-25-069048:0
284 shares@ US$5.650.4% of flowCommon StockSEC:0001104659-25-061040:0
8,333 shares0Common StockSEC:0001104659-25-053097:0
284 shares@ US$6.950.3% of flowCommon StockSEC:0001104659-25-025610:0
285 shares@ US$4.540.2% of flowCommon StockSEC:0001104659-24-130849:0
131 shares@ US$2.790.1% of flowCommon StockSEC:0001104659-24-101766:0
287 shares@ US$2.800.1% of flowCommon StockSEC:0001104659-24-100989:0
283 shares@ US$3.490.2% of flowCommon StockSEC:0001104659-24-073605:0
283 shares@ US$10.710.5% of flowCommon StockSEC:0001104659-24-036792:0
9,204 shares@ US$13.7021.4% of flowCommon StockSEC:0001104659-24-011598:0
9,204 shares@ US$10.9516.7% of flowCommon StockSEC:0001104659-24-004453:0
284 shares@ US$7.640.4% of flowCommon StockSEC:0001104659-23-127726:0
278 shares@ US$9.910.8% of flowCommon StockSEC:0001104659-23-102298:0
283 shares@ US$9.920.5% of flowCommon StockSEC:0001104659-23-073362:0
3,654 shares@ US$0.400.3% of flowCommon StockSEC:0001104659-23-034515:0
12,408 shares@ US$0.400.8% of flowCommon StockSEC:0001104659-22-128640:0
1,348 shares@ US$1.130.3% of flowCommon StockSEC:0001104659-22-101924:0
25 of 32 declarations
